Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
GE Group
GE Group
Activities:
Analysis
X
LinkedIn
Trending Articles
Samsung Biologics signs $1.24bn biopharma manufacturing deal with Asian pharmaceutical giant
The CDMO will work with the client until the end of 2037, and will use its South Korean biomanufacturing site to serve them
Bespak and H&T Presspart announce availability of GMP pilot line for climate-friendly pMDIs
Filling line is on track to supply clinical trial batches utilising climate-friendly propellants HFA-152a and HFO-1234ze
Astellas' Vyloytm plus chemo gains FDA approval for gastric adenocarcinoma
The drug is the first CLDN18.2 targeted therapy to be approved in the US, and can further extend a patient's PFS and OS compared with chemotherapy alone
Axol Bioscience boosts its iPSC bioassay offering with Phenocell acquisition
The acquisition will extend Axol's range of iPSC-derived cell lines, including skin and retinal cells — while also expanding its drug discovery services
How AI and GenAI will revolutionise the healthcare industry
Artificial intelligence — and particularly its newest iteration, generative artificial intelligence (GenAI) — could bring significant changes to the way we live, work and...
Upcoming event
Lab Innovations
30-31 October 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Chime Biologics announces $190m funds to accelerate capacity expansion
The China-based CDMO has plans to increase the total manufacturing capacity to more than 140,000 L within the next 5 years
Ingredients
GE Healthcare collaborates to develop ligands for AAV purification
Australian Children’s Medical Research Institute and GE have agreed to develop new affinity ligands for the purification of adeno-associated viral (AAV) vectors used in gene therapies
Manufacturing
GE Healthcare Life Sciences launches software for cell therapy workflow
The SpinOculation C-Pro Protocol software closes and automates the cell transduction step
Research & Development
New Harvard consortium focuses on advanced bioproduction
The overarching mission of the collaboration is to catalyse the development of transformative therapies by shortening the path between research and clinical application
Manufacturing
GE Healthcare launches new KUBio box for viral vector manufacturing
KUBio box is the latest addition to the KUBio modular bioprocessing portfolio
Ingredients
Research partnership removes bottleneck from AAV development
CPI, Cobra Biologics and GE Healthcare Life Sciences have developed a scalable, cost-effective purification process for adeno-associated viruses
Design & Build
GE Healthcare and Germfree working on modular bioprocessing solution
The project is a rapidly deployable process-ready cleanroom and bioprocessing platforms for biotherapeutics such as gene therapy
Subscribe now